Fabiana Rollini

4.6k total citations · 1 hit paper
112 papers, 2.5k citations indexed

About

Fabiana Rollini is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Fabiana Rollini has authored 112 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Cardiology and Cardiovascular Medicine, 56 papers in Surgery and 23 papers in Internal Medicine. Recurrent topics in Fabiana Rollini's work include Antiplatelet Therapy and Cardiovascular Diseases (90 papers), Coronary Interventions and Diagnostics (34 papers) and Acute Myocardial Infarction Research (32 papers). Fabiana Rollini is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (90 papers), Coronary Interventions and Diagnostics (34 papers) and Acute Myocardial Infarction Research (32 papers). Fabiana Rollini collaborates with scholars based in United States, Italy and South Korea. Fabiana Rollini's co-authors include Dominick J. Angiolillo, Francesco Franchi, Theodore A. Bass, Mattía Galli, Martin M. Zenni, Davide Capodanno, Jung Rae Cho, Luis A. Guzmán, Latonya Been and Jae Youn Moon and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Fabiana Rollini

105 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis

2021 132 citations Mattía Galli, Stefano Benenati et al. profile →

Peers

Countries citing papers authored by Fabiana Rollini

Since Specialization

Citations

This map shows the geographic impact of Fabiana Rollini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabiana Rollini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabiana Rollini more than expected).

Fields of papers citing papers by Fabiana Rollini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabiana Rollini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabiana Rollini. The network helps show where Fabiana Rollini may publish in the future.

Co-authorship network of co-authors of Fabiana Rollini

This figure shows the co-authorship network connecting the top 25 collaborators of Fabiana Rollini. A scholar is included among the top collaborators of Fabiana Rollini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabiana Rollini. Fabiana Rollini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD 2024 ·JACC Basic to Translational Science ·Luis Ortega‐Paz, Francesco Franchi, Fabiana Rollini, Mattía Galli, Latonya Been, (unknown), (unknown), (unknown), Andrea Rivas, (unknown), Andrés M. Pineda, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, (unknown), Taimour Langaee, Joseph A. Jakubowski, Larisa H. Cavallari, Dominick J. Angiolillo	2
2	Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes 2023 ·Vascular Pharmacology ·William A. Parker, Dominick J. Angiolillo, Fabiana Rollini, Francesco Franchi, Marc P. Bonaca, Deepak L. Bhatt, Philippe Gabríel Steg, (unknown), Mark R. Thomas, Heather M. Judge, Marc S. Sabatine, Robert F. Storey	2
3	Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study. 2023 ·PubMed ·Francesco Franchi, Luis Ortega‐Paz, Fabiana Rollini, Latonya Been, Andrea Rivas, (unknown), (unknown), Andrés M. Pineda, Siva Suryadevara, Daniel Soffer, (unknown), Dominick J. Angiolillo	9
4	Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study 2023 ·Thrombosis and Haemostasis ·Luis Ortega‐Paz, Francesco Franchi, Fabiana Rollini, Mattía Galli, Latonya Been, (unknown), (unknown), (unknown), Andrea Rivas, (unknown), Andrés M. Pineda, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, Lisa K. Jennings, Dominick J. Angiolillo	9
5	Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis 2023 ·Thrombosis and Haemostasis ·Mattía Galli, Renzo Laborante, Luis Ortega‐Paz, Francesco Franchi, Fabiana Rollini, Domenico D’Amario, Davide Capodanno, Elena Tremoli, (unknown), Roxana Mehran, Dominick J. Angiolillo	36
6	Factor XI inhibitors in early clinical trials: a meta-analysis 2023 ·European Heart Journal ·Mattía Galli, Renzo Laborante, Luis Ortega‐Paz, Francesco Franchi, Fabiana Rollini, Domenico D’Amario, Davide Capodanno, Elena Tremoli, C. Michael Gibson, Roxana Mehran, Dominick J. Angiolillo	2
7	Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention 2023 ·JACC: Cardiovascular Interventions ·Francesco Franchi, Fabiana Rollini, Luis Ortega‐Paz, Latonya Been, (unknown), Mattía Galli, (unknown), (unknown), (unknown), (unknown), Andrea Rivas, Andrés M. Pineda, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, (unknown), Birgit Reiter, Bernd Jilma, Dominick J. Angiolillo	10
8	Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy 2022 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Mattía Galli, Francesco Franchi, Fabiana Rollini, Latonya Been, (unknown), Andrea Rivas, (unknown), Sida Jia, (unknown), Chang Hoon Lee, Andrés M. Pineda, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, Tobias Geisler, Lisa K. Jennings, Theodore A. Bass, Dominick J. Angiolillo	17
9	Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor 2022 ·JACC: Cardiovascular Interventions ·Francesco Franchi, Luis Ortega‐Paz, Fabiana Rollini, Mattía Galli, Latonya Been, (unknown), (unknown), (unknown), Andrea Rivas, (unknown), Andrés M. Pineda, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, Birgit Reiter, Bernd Jilma, Dominick J. Angiolillo	18
10	Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease 2022 ·Thrombosis and Haemostasis ·Mattía Galli, Francesco Franchi, Fabiana Rollini, Latonya Been, (unknown), Andrea Rivas, (unknown), Sida Jia, (unknown), Chang Hoon Lee, Andrés M. Pineda, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, Tobias Geisler, Lisa K. Jennings, Theodore A. Bass, Dominick J. Angiolillo	21
11	Precision Medicine in Interventional Cardiology: Implications for Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention 2022 ·Pharmacogenomics ·Mattía Galli, Luis Ortega‐Paz, Francesco Franchi, Fabiana Rollini, Dominick J. Angiolillo	26
12	Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials 2021 ·European Heart Journal ·Mattía Galli, Stefano Benenati, Francesco Franchi, Fabiana Rollini, Davide Capodanno, Giuseppe Biondi‐Zoccai, Giovanni Maria Vescovo, Larisa H. Cavallari, Behnood Bikdeli, Jurriën M. ten Berg, Roxana Mehran, C. Michael Gibson, Filippo Crea, Naveen L. Pereira, Dirk Sibbing, Dominick J. Angiolillo	95
13	Role of platelet function and genetic testing in patients undergoing percutaneous coronary intervention 2021 ·Trends in Cardiovascular Medicine ·Mattía Galli, Francesco Franchi, Fabiana Rollini, Dominick J. Angiolillo	31
14	Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials 2021 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Luis Ortega‐Paz, Mattía Galli, Davide Capodanno, Francesco Franchi, Fabiana Rollini, Behnood Bikdeli, Roxana Mehran, Gilles Montalescot, C. Michael Gibson, Renato D. Lópes, Felicita Andreotti, Dominick J. Angiolillo	39
15	Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations 2021 ·Expert Review of Clinical Pharmacology ·Mattía Galli, Francesco Franchi, Fabiana Rollini, Larisa H. Cavallari, Davide Capodanno, Filippo Crea, Dominick J. Angiolillo	33
16	Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease 2021 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Francesco Franchi, Fabiana Rollini, Latonya Been, (unknown), (unknown), Andrea Rivas, (unknown), Sida Jia, (unknown), Chang Hoon Lee, Andrés M. Pineda, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, Theodore A. Bass, Dominick J. Angiolillo	5
17	Mesenteric ischemia presenting as a myocardial infarction 2018 ·Journal of Geriatric Cardiology ·(unknown), Karan Seegobin, Dmitry Yaranov, Fabiana Rollini	2
18	Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease 2016 ·Circulation ·Francesco Franchi, Fabiana Rollini, Niti R. Aggarwal, Jenny Hu, Megha Kureti, (unknown), Valeria E. Duarte, Jung Rae Cho, Latonya Been, Martin M. Zenni, Theodore A. Bass, Dominick J. Angiolillo	70
19	Abstract 19115: Effect of the Peripheral Opioid Receptor Antagonist Methylnaltrexone on the Pharmacokinetic and Pharmacodynamic Profiles of Ticagrelor in Patients Receiving Morphine: A Prospective Randomized Placebo-Controlled Trial 2016 ·Circulation ·Francesco Franchi, Fabiana Rollini, Yongwhi Park, Jenny Hu, Megha Kureti, (unknown), (unknown), Gabriel Faz, Dmitry Yaranov, Latonya Been, (unknown), Daniel Soffer, Martin M. Zenni, Theodore A. Bass, Dominick J. Angiolillo	2
20	Carotid plaque characterisation by IVUS-VH during carotid stenting: the "eyes wide shut" between plaque morphology and symptoms. 2011 ·PubMed ·Luigi Politi, Alessandro Aprile, Fabiana Rollini, (unknown), Giuseppe Biondi‐Zoccai, Alessandro Mauriello, Maria Grazia Modena, Giuseppe Sangiorgi	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact